APEX Trial

Revision as of 15:38, 19 June 2013 by Matt Pijoan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Overview

The APEX Trial is a trial of the Factor Xa inhibitor betrixaban in the management of medically ill patients.